Telix Pharmaceuticals Limited Stock
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.66 AUD | -3.36% |
|
-6.09% | +30.89% |
| Market Cap | 4.98B 3.48B 3.06B 2.85B 2.61B 4.91B 335B 33.79B 13.2B 165B 13.08B 12.79B 570B | P/E 2026 * |
212x | P/E 2027 * | 90.4x |
|---|---|---|---|---|---|
| Enterprise Value | 5.39B 3.77B 3.31B 3.08B 2.82B 5.31B 363B 36.55B 14.28B 178B 14.14B 13.84B 617B | EV / Sales 2026 * |
3.84x | EV / Sales 2027 * | 3.35x |
| Free-Float |
83.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | -3.36% | ||
| 1 week | -6.09% | ||
| Current month | -11.58% | ||
| 1 month | +0.69% | ||
| 3 months | +1.59% | ||
| 6 months | +33.88% | ||
| Current year | +30.89% |
| 1 week | 14.4 |  | 15.73 |
| 1 month | 14.4 | | 17.76 |
| Current year | 8.26 | | 17.76 |
| 1 year | 8.26 | | 21.94 |
| 3 years | 8.2 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 03/01/2017 | |
Darren Smith
DFI | Director of Finance/CFO | 60 | 31/07/2022 |
Mary Jessel
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Gill
BRD | Director/Board Member | 71 | 11/05/2026 |
William Jellison
BRD | Director/Board Member | 68 | 11/05/2026 |
| Director/Board Member | 51 | 03/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/11/26 A | Buy | Director | 10,200 | 0.0030% | ||
| 5/26/26 A | Free | Director | 30,048 | 0.0089% | ||
| 5/26/26 A | Free | Founder | 339,845 | 0.1001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.36% | -6.09% | -31.24% | +41.51% | 3.59B | |
| +1.07% | -4.73% | -3.96% | +11.63% | 46.35B | |
| +0.95% | +1.02% | +405.27% | +624.98% | 40.13B | |
| -11.75% | +4.75% | +10.25% | +67.40% | 36.33B | |
| +5.33% | +1.26% | +4.00% | -8.46% | 34.6B | |
| +3.14% | +1.02% | +3.72% | +34.86% | 26.77B | |
| +7.24% | -2.85% | - | - | 16.66B | |
| +4.46% | +12.64% | +32.93% | +145.29% | 16.91B | |
| +0.42% | -4.46% | +4.80% | +8.67% | 13.05B | |
| +5.45% | -2.11% | -14.62% | -31.38% | 13.05B | |
| Average | -0.04% | +0.63% | +45.68% | +99.39% | 24.74B | |
| Weighted average by Cap. | +0.44% | +0.72% | +73.69% | +134.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.4B 982M 862M 802M 736M 1.38B 94.54B 9.52B 3.72B 46.48B 3.69B 3.61B 161B | 1.62B 1.14B 998M 928M 852M 1.6B 109B 11.02B 4.31B 53.8B 4.27B 4.17B 186B |
| Net income | 19.8M 13.85M 12.16M 11.31M 10.38M 19.5M 1.33B 134M 52.47M 655M 51.97M 50.85M 2.27B | 41.97M 29.35M 25.78M 23.97M 22M 41.33M 2.83B 285M 111M 1.39B 110M 108M 4.8B |
| Net Debt | 407M 285M 250M 232M 213M 401M 27.4B 2.76B 1.08B 13.47B 1.07B 1.04B 46.57B | 460M 322M 283M 263M 241M 453M 30.98B 3.12B 1.22B 15.23B 1.21B 1.18B 52.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | A$14.66 | -3.36% | 2,022,462 |
| 23/07/26 | A$15.17 | +2.09% | 1,461,693 |
| 22/07/26 | A$14.86 | -2.94% | 1,491,901 |
| 21/07/26 | A$15.31 | +1.39% | 2,441,634 |
| 20/07/26 | A$15.10 | +1.27% | 920,820 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
